
KCAS Bio
Olathe, KS, United Stateskcasbio.comFrom their website, Nov 2026
- GLP
Work here? Claim this listing
About
KCAS Bio is a bioanalytical and biomarker contract research organization serving pharmaceutical, biotechnology, and emerging biopharmaceutical companies. It supports drug development from discovery through clinical development with sites in the United States and Europe, plus a partner site in Melbourne, Australia.
Services
Small Molecule Bioanalysis
GLP/GCP-compliant bioanalysis of small molecules using LC-MS/MS platforms to quantify drugs, metabolites, and biomarkers from discovery through clinical stages.
LBA for Large Molecules
Ligand binding assay services for large molecules, including tailored assay development from early discovery through clinical studies.
Hybrid LC-MS/MS for Large Molecules
High-sensitivity bioanalytical services for complex and emerging large molecule therapeutics using hybrid LC-MS/MS.
Immunogenicity Testing
Testing to assess immune responses to therapeutic candidates.
Pharmacokinetics (PK)
Bioanalytical support for pharmacokinetic studies.
Pharmacodynamics (PD)
Bioanalytical support for pharmacodynamic studies.
Biomarker Testing
Biomarker analysis to support drug development programs.
Flow Cytometry
Flow cytometry services for bioanalysis and immune-response work.
3 more services
- Molecular Biology
- Dose Formulation
- Central Lab Technology
Capabilities
- Assays and studies
- Bioanalysis
- LC-MS/MS
- Small molecules
- Flow cytometry
- Immunogenicity
- PK/PD
17 more
- qPCR
- ELISA
- Antibodies
- ADCs
- Ligand binding assays
- ELISpot
- Meso Scale Discovery
- Luminex
- NULISA
- AlphaLISA
- Hybrid LC-MS/MS
- ddPCR
- LC-UV-Vis/Fluorescence
- ELISA Testing
- ELISpot Testing
- NULISA – Argo HT
- Liquid Chromatography Mass Spectrometry
- Scale and capacity
- Kansas City headquarters and largest site
- Philadelphia site: 26,000 ft² (2,500 m²) facility
- Kansas City site: 70,000 ft² (6,500 m²)
- More than 315 approved drugs on the market
- More than 6,200 proprietary and non-proprietary assays
- More than 20 FDA audits with no major findings
- 25+ FDA inspections
- Therapeutic areas
- Allergy & Immunology
- Cardiovascular
- Dermatology
- Gastrointestinal
- Infectious Diseases
- Inflammation & Pain
7 more
- Metabolic
- Neurology & CNS
- Oncology
- Ophthalmology
- Rare Diseases
- Renal
- Respiratory
Instruments and platforms
- Meso Scale Discovery
- ELISA
- ELISpot
- Luminex
- NULISA – Argo HT
- AlphaLISA
- Liquid Chromatography Mass Spectrometry
- Hybrid LC-MS/MS
- qPCR
- ddPCR
- Flow Cytometry
- LC-UV-Vis/Fluorescence
Modalities and species
- Modalities
- Small molecule
- Antibody
- Bispecific
- ADC
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Scope: development services
Details
- Type
- CRO
- Address
- 10830 S. Clay Blair Blvd., Olathe, KS 66061
- Sites
- Kansas City, United States · Philadelphia, United States · Lyon, France · Melbourne, Australia
- Serves
- Global, United States, Europe, APAC